← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2009Last known activity
Sep 30, 2025
Timeline
2000s
- Jun 1, 2003
Betta Pharmaceuticals Co.,Ltd.— Founded
Drugs by trial phase (34 distinct, 79 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Brain Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Esophageal Neoplasms
- Hepatic Insufficiency
- Leukemia
- Leukemia, Lymphoid
- Liver Failure
- Lung Neoplasms
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Neurilemmoma
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Neurofibromatosis 2
- Neuroma, Acoustic
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Psoriasis
- Small Cell Lung Carcinoma
Recent trials (50)
- NCT07181499Lead sponsorPhase 2Sep 30, 2025
- NCT06885840Lead sponsorPhase 2Mar 31, 2025
- NCT06780839CollaboratorPhase 2Jan 15, 2025
- NCT06641609Lead sponsorPhase 1Dec 13, 2024
- NCT06492525Lead sponsorPhase 1Jul 31, 2024
- NCT06015568Lead sponsorPhase 1Sep 1, 2023
- NCT05869240Lead sponsorPhase 1/Phase 2May 16, 2023
- NCT05843305Lead sponsorPhase 1Apr 28, 2023
- NCT05789602Lead sponsorPhase 1Apr 18, 2023
- NCT06041776Lead sponsorPhase 3Mar 28, 2023
- NCT05433480Lead sponsorPhase 3Jun 30, 2022
- NCT05341557Lead sponsorPhase 1Jun 30, 2022
- NCT05369312Lead sponsorPhase 1Jun 30, 2022
- NCT05341583Lead sponsorPhase 3May 24, 2022
- NCT05316259Lead sponsorPhase 1Apr 22, 2022
Details
- Founded
- Hangzhou, CN Jun 1, 2003
- Last known activity
- Sep 30, 2025